Table 3.
List of some important antimicrobial peptides and their respective clinical phases (Mahlapuu et al., 2016).
| S.No | Antimicrobial Peptides | Clinical Phase | Administration | Clinical Trial Identifier |
|---|---|---|---|---|
| 1. | Iseganan (IB-367) | Phase III | Oral solution | NCT00022373 |
| 2. | Pexiganan (MSI-78) | Phase III | Topical cream | NCT00563394,NCT00563433 |
| 3. | Omiganan | Phase II/III | Topical gel | NCT00231153,NCT01784133 |
| 4. | Lytixar (LTX-109) | Phase I/II | Topical Hydrogel | NCT01223222,NCT01803035,NCT01158235 |
| 5. | hLF1-11 | Phase I/II | Intravenous treatment (in saline) | NCT00509938 |